Patient-Specific Vaccines Derived from Autologous Tumor Cell Lines as Active Specific Immunotherapy: Results of Exploratory Phase I/II Trials in Patients with Metastatic Melanoma
2007 ◽
Vol 22
(3)
◽
pp. 309-321
◽
2001 ◽
Vol 39
(1-2)
◽
pp. 115-123
◽
Keyword(s):
2015 ◽
Keyword(s):
1998 ◽
Vol 13
(3)
◽
pp. 165-176
◽
Keyword(s):
2014 ◽
Vol 29
(2)
◽
pp. 53-57
◽
Keyword(s):
2002 ◽
Vol 17
(1)
◽
pp. 51-66
◽
Keyword(s):
Keyword(s):
1993 ◽
Vol 690
(1)
◽
pp. 135-146
◽